Year archive

JW (Cayman) Therapeutics Co. Ltd — 2022 filings

All 70 regulatory filings released by JW (Cayman) Therapeutics Co. Ltd (2126) in 2022, sourced directly from the official regulator.

70 Filings

2022 Period

2022 filings (70)

Filing	Released	Lang
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2022-12-30	English
RESIGNATION OF DIRECTOR CHANGE OF COMPOSITION OF BOARD COMMITTEES AND NON-COMPLIANCE WITH THE LISTING RULES Board/Management Information	2022-12-30	English
Documents on Display Regulatory Filings	2022-12-29	English
Notification Letter and Change Request Form to Registered Holders Report Publication Announcement	2022-12-29	English
Notification Letter and Request Form to Non-registered Holders Report Publication Announcement	2022-12-29	English
Form of proxy for the Extraordinary General Meeting to be held on January 17, 2023 Proxy Solicitation & Information Statement	2022-12-29	English
NOTICE OF EXTRAORDINARY GENERAL MEETING AGM Information	2022-12-29	English
CONNECTED TRANSACTION AND CONTINUING CONNECTED TRANSACTION IN RELATION TO LICENSE AND COLLABORATION AGREEMENT Proxy Solicitation & Information Statement	2022-12-29	English
CONNECTED TRANSACTION AND CONTINUING CONNECTED TRANSACTION IN RELATION TO LICENSE AND COLLABORATION AGREEMENT Capital/Financing Update	2022-12-21	English
GRANT OF SHARE OPTIONS AND GRANT OF RESTRICTED SHARE UNITS Share Issue/Capital Change	2022-12-18	English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE LATEST CLINICAL DATA ON CARTEYVA IN FOLLICULAR LYMPHOMA AND MANTLE CELL LYMPHOMA AT THE 64th AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING Regulatory Filings	2022-12-12	English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON DECEMBER 2, 2022 Declaration of Voting Results & Voting Rights Announcements	2022-12-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022 Regulatory Filings	2022-12-02	English
Redacted Collaboration Agreement Regulatory Filings	2022-11-16	English
Notification Letter and Change Request Form to Registered Holders Report Publication Announcement	2022-11-16	English
Notification Letter and Request Form to Non-registered Holders Report Publication Announcement	2022-11-16	English
Form of proxy for the Extraordinary General Meeting to be held on December 2, 2022 Proxy Solicitation & Information Statement	2022-11-16	English
NOTICE OF EXTRAORDINARY GENERAL MEETING AGM Information	2022-11-16	English
MAJOR TRANSACTION IN RELATION TO COLLABORATION AGREEMENT AND NOTICE OF EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2022-11-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022 Regulatory Filings	2022-11-03	English
MAJOR TRANSACTION IN RELATION TO COLLABORATION AGREEMENT Regulatory Filings	2022-10-27	English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE - NMPA APPROVAL OF RELMA-CEL IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA Regulatory Filings	2022-10-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022 Regulatory Filings	2022-10-07	English
GRANT OF SHARE OPTIONS AND GRANT OF RESTRICTED SHARE UNITS Director's Dealing	2022-09-30	English
Notification Letter and Change Request Form to Registered Holders Report Publication Announcement	2022-09-28	English
Notification Letter and Request Form to Non-registered Holders Report Publication Announcement	2022-09-28	English
2022 INTERIM REPORT Interim / Quarterly Report H1 2022	2022-09-28	English
VOLUNTARY ANNOUNCEMENT - UNUSUAL PRICE AND TRADING VOLUME MOVEMENT Regulatory Filings	2022-09-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022 Regulatory Filings	2022-09-02	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2022 Interim / Quarterly Report H1 2022	2022-08-30	English
NOTICE OF BOARD MEETING Report Publication Announcement	2022-08-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022 Regulatory Filings	2022-08-03	English
GRANT OF EXTENSION OF WAIVER FROM STRICT COMPLIANCE WITH RULES 14A.52 AND 14A.53 OF THE LISTING RULES UNDER THE LICENSE AND STRATEGIC ALLIANCE AGREEMENT Regulatory Filings	2022-07-26	English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE INITIAL OF CLINICAL STUDY OF JWATM204 IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA Capital/Financing Update	2022-07-04	English
Next Day Disclosure Return Transaction in Own Shares	2022-07-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022 Regulatory Filings	2022-07-04	English
EIGHTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Governance Information	2022-06-29	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 29, 2022 Declaration of Voting Results & Voting Rights Announcements	2022-06-29	English
GRANT OF SHARE OPTIONS AND GRANT OF RESTRICTED SHARE UNITS Capital/Financing Update	2022-06-24	English
UPDATE ON THE ARRANGEMENTS TO ANNUAL GENERAL MEETING TO BE HELD ON JUNE 29, 2022 AGM Information	2022-06-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022 Regulatory Filings	2022-06-07	English
VOLUNTARY ANNOUNCEMENT RESEARCH AND DEVELOPMENT UPDATE LATEST DATA OF Carteyva AT 2022 AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING Regulatory Filings	2022-06-05	English
Notification Letter and Request Form to Non-registered Holders Report Publication Announcement	2022-06-02	English
Notification Letter and Change Request Form to Registered Holders Report Publication Announcement	2022-06-02	English
Form of proxy for the Annual General Meeting to be held on June 29, 2022 AGM Information	2022-06-02	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2022-06-02	English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS AND RE-APPOINTMENT OF AUDITOR AND ADOPTION OF NEW ARTICLES OF ASSOCIATION AND NOTICE OF ANNUA AGM Information	2022-06-02	English
PROPOSED ADOPTION OF NEW ARTICLES OF ASSOCIATION Governance Information	2022-06-02	English
NOTIFICATION LETTER Report Publication Announcement	2022-05-27	English
2021 Environmental, Social and Governance Report Environmental & Social Information	2022-05-27	English
CHANGE OF DATE OF ANNUAL GENERAL MEETING AND BOOK CLOSURE PERIOD AGM Information	2022-05-12	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022 Regulatory Filings	2022-05-06	English
Notification Letter and Request Form to Non-registered Holders Report Publication Announcement	2022-04-29	English
Notification Letter and Change Request Form to Registered Holders Report Publication Announcement	2022-04-29	English
2021 ANNUAL REPORT Annual Report FY 2021	2022-04-29	English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE - IND APPROVAL FOR THE CLINICAL TRIAL OF Carteyva IN PEDIATRIC AND YOUNG ADULT PATIENTS Regulatory Filings	2022-04-20	English
SUPPLEMENTAL ANNOUNCEMENT - CONNECTED TRANSACTION - FINANCIAL ASSISTANCE TO CONNECTED PERSON Capital/Financing Update	2022-04-14	English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE RECEIPT OF BREAKTHROUGH THERAPY DESIGNATION FOR Carteyva IN MANTLE CELL LYMPHOMA IN CHINA Regulatory Filings	2022-04-03	English
Next Day Disclosure Return Share Issue/Capital Change	2022-04-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022 Regulatory Filings	2022-04-01	English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE IND APPROVAL FOR THE PIVOTAL CLINICAL TRIAL OF Carteyva Capital/Financing Update	2022-03-31	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021 Annual Report FY 2021	2022-03-23	English
NOTICE OF BOARD MEETING Regulatory Filings	2022-03-10	English
CONNECTED TRANSACTION FINANCIAL ASSISTANCE TO CONNECTED PERSON Capital/Financing Update	2022-03-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022 Regulatory Filings	2022-03-04	English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE ACCEPTANCE OF THE SUPPLEMENTAL NEW DRUG APPLICATION FOR Carteyva Regulatory Filings	2022-02-27	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022 Share Issue/Capital Change	2022-02-09	English
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE APPOINTMENTS OF CHIEF SCIENTIFIC OFFICER AND SENIOR VICE PRESIDENT OF CORPORATE DEVELOPMENT Board/Management Information	2022-01-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021 Regulatory Filings	2022-01-05	English
Next Day Disclosure Return Share Issue/Capital Change	2022-01-03	English